It can activate the downstream nuclear factor kappa-B (NF-κB) pathway after cerebral ischemia and promote the inflammatory response (Wang et al., 2014) while inhibiting the activation of the MAPK pathway can reduce the activation of the inflammatory response and have neuroprotective effects (Guo et al., 2012). The gene discussed is NFKB1; the disease is brain ischemia.